Lebwohl, M. G.; Sugarman, J.; Pariser, D. M.; Bagel, J.; Trickett, C.; Jacobson, A.; Israel, R. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. J of Skin 2020, 4, s38.